Smith & Nephew SNATS PE Ratio 2010-2025 | SNN
Current and historical p/e ratio for Smith & Nephew SNATS (SNN) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Smith & Nephew SNATS PE ratio as of August 27, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Smith & Nephew SNATS PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-27 | 37.25 | 0.00 | |
| 2025-06-30 | 30.63 | 0 | 0.00 |
| 2024-12-31 | 24.18 | 0 | 0.00 |
| 2024-06-30 | 24.14 | 0 | 0.00 |
| 2023-12-31 | 26.08 | 0 | 0.00 |
| 2023-06-30 | 30.46 | 0 | 0.00 |
| 2022-12-31 | 24.97 | 0 | 0.00 |
| 2022-06-30 | 25.60 | 0 | 0.00 |
| 2021-12-31 | 31.29 | 0 | 0.00 |
| 2021-06-30 | 38.94 | 0 | 0.00 |
| 2020-12-31 | 37.35 | 0 | 0.00 |
| 2020-06-30 | 33.51 | 0 | 0.00 |
| 2019-12-31 | 41.68 | 0 | 0.00 |
| 2019-06-30 | 37.51 | 0 | 0.00 |
| 2018-12-31 | 31.85 | 0 | 0.00 |
| 2018-06-30 | 31.74 | 0 | 0.00 |
| 2017-12-31 | 29.25 | 0 | 0.00 |
| 2017-06-30 | 28.92 | 0 | 0.00 |
| 2016-12-31 | 24.67 | $0.36 | 68.53 |
| 2015-12-31 | 28.66 | $0.59 | 48.58 |
| 2015-06-30 | 27.15 | $0.79 | 34.37 |
| 2014-12-31 | 29.07 | $1.13 | 25.82 |
| 2014-09-30 | 26.46 | $1.13 | 23.50 |
| 2014-06-30 | 28.06 | $1.16 | 24.11 |
| 2014-03-31 | 23.76 | $1.25 | 19.04 |
| 2013-12-31 | 22.29 | $1.23 | 18.15 |
| 2013-09-30 | 19.22 | $1.18 | 16.24 |
| 2013-06-30 | 17.27 | $1.22 | 14.21 |
| 2013-03-31 | 17.53 | $1.59 | 11.04 |
| 2012-12-31 | 16.82 | $1.63 | 10.31 |
| 2012-09-30 | 16.58 | $1.63 | 10.18 |
| 2012-06-30 | 15.04 | $1.63 | 9.24 |
| 2012-03-31 | 15.02 | $1.31 | 11.45 |
| 2011-12-31 | 14.33 | $1.30 | 11.02 |
| 2011-09-30 | 13.20 | $1.40 | 9.45 |
| 2011-06-30 | 16.00 | $1.40 | 11.46 |
| 2011-03-31 | 16.51 | $1.36 | 12.11 |
| 2010-12-31 | 15.38 | $1.38 | 11.18 |
| 2010-09-30 | 13.20 | $1.26 | 10.51 |
| 2010-06-30 | 13.67 | $1.24 | 10.99 |
| 2010-03-31 | 14.44 | $1.20 | 11.99 |
| 2009-12-31 | 14.78 | $1.06 | 13.89 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $16.337B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.027B | 26.85 |
| Boston Scientific (BSX) | United States | $157.644B | 37.59 |
| Stryker (SYK) | United States | $150.755B | 30.69 |
| EssilorLuxottica (ESLOY) | France | $144.001B | 0.00 |
| Medtronic (MDT) | Ireland | $118.256B | 16.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.628B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.188B | 24.69 |
| ResMed (RMD) | United States | $41.753B | 29.86 |
| GE HealthCare Technologies (GEHC) | United States | $33.827B | 15.90 |
| Agilent Technologies (A) | United States | $33.605B | 21.91 |
| Koninklijke Philips (PHG) | Netherlands | $26.779B | 17.71 |
| Terumo (TRUMY) | Japan | $26.532B | 31.44 |
| Insulet (PODD) | United States | $23.358B | 78.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.303B | 13.56 |
| Baxter (BAX) | United States | $12.584B | 9.72 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.027B | 29.48 |
| Lantheus Holdings (LNTH) | United States | $3.785B | 10.23 |
| Envista Holdings (NVST) | United States | $3.513B | 24.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.268B | 14.50 |
| Perrigo (PRGO) | Ireland | $3.265B | 8.15 |
| ICU Medical (ICUI) | United States | $3.109B | 21.17 |
| Haemonetics (HAE) | United States | $2.661B | 11.88 |
| LeMaitre Vascular (LMAT) | United States | $2.157B | 46.25 |
| Acuren (TIC) | United States | $2.156B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.117B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.896B | 11.93 |
| Green Thumb Industries (GTBIF) | United States | $1.888B | 81.09 |
| AtriCure (ATRC) | United States | $1.882B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.596B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.323B | 16.91 |
| AdaptHealth (AHCO) | United States | $1.246B | 17.71 |
| BioLife Solutions (BLFS) | United States | $1.229B | 2565.00 |
| Neogen (NEOG) | United States | $1.223B | 19.41 |
| Kestra Medical Technologies (KMTS) | United States | $0.952B | 0.00 |
| InMode (INMD) | Israel | $0.941B | 8.70 |
| Valneva SE (VALN) | France | $0.762B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.683B | 0.00 |
| SNDL (SNDL) | Canada | $0.649B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.62 |
| Surmodics (SRDX) | United States | $0.496B | 0.00 |
| Evolus (EOLS) | United States | $0.495B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 16.11 |
| CeriBell (CBLL) | United States | $0.420B | 0.00 |
| Owens & Minor (OMI) | United States | $0.387B | 3.43 |
| Sanuwave Health (SNWV) | United States | $0.360B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.353B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Brainsway (BWAY) | Israel | $0.301B | 61.15 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.299B | 0.00 |
| Omeros (OMER) | United States | $0.298B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.296B | 0.00 |
| High Tide (HITI) | Canada | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 20.74 |
| Cerus (CERS) | United States | $0.255B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.255B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.241B | 0.00 |
| Organigram Global (OGI) | Canada | $0.221B | 0.00 |
| Quanterix (QTRX) | United States | $0.218B | 0.00 |
| Exagen (XGN) | United States | $0.218B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.195B | 16.24 |
| FitLife Brands (FTLF) | United States | $0.173B | 21.31 |
| Biote (BTMD) | United States | $0.164B | 5.43 |
| Jushi Holdings (JUSHF) | United States | $0.151B | 0.00 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| MacroGenics (MGNX) | United States | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.32 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 32.90 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.67 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.62 |
| Trinity Biotech (TRIB) | Ireland | $0.027B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |